Acquired resistance to zoledronic acid and the parallel acquisition of an aggressive phenotype are mediated by p38-MAP kinase activation in prostate cancer cells
出版年份 2013 全文链接
标题
Acquired resistance to zoledronic acid and the parallel acquisition of an aggressive phenotype are mediated by p38-MAP kinase activation in prostate cancer cells
作者
关键词
-
出版物
Cell Death & Disease
Volume 4, Issue 5, Pages e641-e641
出版商
Springer Nature
发表日期
2013-05-24
DOI
10.1038/cddis.2013.165
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Metastatic Colonization Requires the Repression of the Epithelial-Mesenchymal Transition Inducer Prrx1
- (2012) Oscar H. Ocaña et al. CANCER CELL
- Novel Aspects of Mevalonate Pathway Inhibitors as Antitumor Agents
- (2012) M. Thurnher et al. CLINICAL CANCER RESEARCH
- Effects of Bone-Targeted Agents on Cancer Progression and Mortality
- (2012) R. Coleman et al. JNCI-Journal of the National Cancer Institute
- TNFα-Induced Apoptosis Enabled by CCN1/CYR61: Pathways of Reactive Oxygen Species Generation and Cytochrome c Release
- (2012) Vladislava Juric et al. PLoS One
- CCL11 (eotaxin-1): A new diagnostic serum marker for prostate cancer
- (2012) Manisha Agarwal et al. PROSTATE
- MYC and Metastasis
- (2011) A. Wolfer et al. CANCER RESEARCH
- Pathways of chemotherapy resistance in castration-resistant prostate cancer
- (2011) K. L. Mahon et al. ENDOCRINE-RELATED CANCER
- Emerging Therapies to Prevent Skeletal Morbidity in Men With Prostate Cancer
- (2011) Philip J. Saylor et al. JOURNAL OF CLINICAL ONCOLOGY
- Epithelial-to-mesenchymal transition in prostate cancer: paradigm or puzzle?
- (2011) Jones T. Nauseef et al. Nature Reviews Urology
- Prognostic relevance of Bcl-2 overexpression in surgically treated prostate cancer is not caused by increased copy number or translocation of the gene
- (2011) A. Fleischmann et al. PROSTATE
- HAb18G/CD147 cell-cell contacts confer resistance of a HEK293 subpopulation to anoikis in an E-cadherin-dependent manner
- (2010) Xiao-Kui Ma et al. BMC CELL BIOLOGY
- Biochemical and molecular mechanisms of action of bisphosphonates
- (2010) Michael J. Rogers et al. BONE
- Metronomic administration of Zoledronic Acid and Taxotere combination in castration resistant prostate cancer patients: Phase I ZANTE trial
- (2010) Gaetano Facchini et al. CANCER BIOLOGY & THERAPY
- HDAC inhibitor vorinostat enhances the antitumor effect of gefitinib in squamous cell carcinoma of head and neck by modulating ErbB receptor expression and reverting EMT
- (2010) Francesca Bruzzese et al. JOURNAL OF CELLULAR PHYSIOLOGY
- p38 Mitogen-Activated Protein Kinase Promotes Cell Survival in Response to DNA Damage but Is Not Required for the G2 DNA Damage Checkpoint in Human Cancer Cells
- (2010) M. S. Phong et al. MOLECULAR AND CELLULAR BIOLOGY
- Translational Activation of Snail1 and Other Developmentally Regulated Transcription Factors by YB-1 Promotes an Epithelial-Mesenchymal Transition
- (2009) Valentina Evdokimova et al. CANCER CELL
- Emerging roles of chemokines in prostate cancer
- (2009) David Vindrieux et al. ENDOCRINE-RELATED CANCER
- VEGF elicits epithelial-mesenchymal transition (EMT) in prostate intraepithelial neoplasia (PIN)-like cells via an autocrine loop
- (2009) Oscar Gonzalez-Moreno et al. EXPERIMENTAL CELL RESEARCH
- Cyr61 downmodulation potentiates the anticancer effects of zoledronic acid in androgen-independent prostate cancer cells
- (2009) Monica Marra et al. INTERNATIONAL JOURNAL OF CANCER
- Mechanical Regulation of the Proangiogenic Factor CCN1/CYR61 Gene Requires the Combined Activities of MRTF-A and CREB-binding Protein Histone Acetyltransferase
- (2009) Mary Hanna et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Synergistic antitumor effect between vorinostat and topotecan in small cell lung cancer cells is mediated by generation of reactive oxygen species and DNA damage-induced apoptosis
- (2009) F. Bruzzese et al. MOLECULAR CANCER THERAPEUTICS
- Ezrin mediates c-Myc actions in prostate cancer cell invasion
- (2009) Y-C Chuan et al. ONCOGENE
- Farnesyl diphosphate synthase is involved in the resistance to zoledronic acid of osteosarcoma cells
- (2008) B. Ory et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started